Abstract
CA125 dominated performance for ovarian cancer early detection among four serum biomarkers evaluated in EPIC study prediagnostic serum, rising on average 3 years prior to detection. Adding HE4 provided only marginal improvement. This natural history supports annual testing for early detection and highlights the importance of biomarker discovery complementing CA125.
Cite
CITATION STYLE
APA
Skates, S. J. (2016). EPIC early detection of ovarian cancer. Clinical Cancer Research, 22(18), 4542–4544. https://doi.org/10.1158/1078-0432.CCR-16-1391
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free